Key Insights

Highlights

Success Rate

93% trial completion (above average)

Published Results

223 trials with published results (20%)

Research Maturity

812 completed trials (72% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.7%

65 terminated out of 1135 trials

Success Rate

92.6%

+6.0% vs benchmark

Late-Stage Pipeline

17%

189 trials in Phase 3/4

Results Transparency

27%

223 of 812 completed with results

Key Signals

223 with results93% success65 terminated

Data Visualizations

Phase Distribution

893Total
Not Applicable (397)
Early P 1 (7)
P 1 (172)
P 2 (128)
P 3 (126)
P 4 (63)

Trial Status

Completed812
Unknown104
Recruiting79
Terminated65
Active Not Recruiting33
Withdrawn23

Trial Success Rate

92.6%

Benchmark: 86.5%

Based on 812 completed trials

Clinical Trials (1135)

Showing 20 of 20 trials
NCT06238778Phase 2CompletedPrimary

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

NCT06334133Phase 3Active Not RecruitingPrimary

Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

NCT06236256Not ApplicableCompletedPrimary

Advanced Hybrid Closed Loop System (AHCL) in Older Patients With Type 1 Diabetes Mellitus

NCT07222137Phase 3RecruitingPrimary

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

NCT07711275Not ApplicableCompletedPrimary

Hypoglycemia Thresholds in Type 1 Diabetes

NCT07222332Phase 3RecruitingPrimary

A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)

NCT05849753RecruitingPrimary

Breaking Disparities in Access to Advanced Diabetes Technologies in Children With Type 1 Diabetes

NCT06688331Phase 2Recruiting

Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody

NCT03938324Not ApplicableCompleted

Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions

NCT06880835Not ApplicableRecruitingPrimary

Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin Delivery

NCT07090824Phase 1CompletedPrimary

Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes

NCT04786262Phase 3RecruitingPrimary

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

NCT05756361Not ApplicableCompletedPrimary

Family-Based Treatment for Type 1 Diabetes

NCT07076199Phase 3RecruitingPrimary

A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes

NCT06807190RecruitingPrimary

General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus

NCT05937321Not ApplicableActive Not RecruitingPrimary

National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring With Data Sharing in Older Adults With Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.

NCT07160816Active Not RecruitingPrimary

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

NCT05180591Phase 2Active Not RecruitingPrimary

Repeat BCG Vaccinations For The Treatment Of Pediatric Type 1 Diabetes

NCT05014789Not ApplicableCompletedPrimary

Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study

NCT05866900CompletedPrimary

The Impact of Daily Carbohydrate Intake on Glycemic Control in Children and Adolescents With Type 1 Diabetes Using an Advanced Hybrid Closed-loop System

Scroll to load more

Research Network

Activity Timeline